Submission Details
| 510(k) Number | K980900 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 10, 1998 |
| Decision Date | March 26, 1998 |
| Days to Decision | 16 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K980900 is an FDA 510(k) clearance for the N-ASSAY CPK-L, a Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes (Class II — Special Controls, product code CGS), submitted by Crestat Diagnostics, Inc. (Seattle, US). The FDA issued a Cleared decision on March 26, 1998, 16 days after receiving the submission on March 10, 1998. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1215.
| 510(k) Number | K980900 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 10, 1998 |
| Decision Date | March 26, 1998 |
| Days to Decision | 16 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CGS — Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1215 |